Journal article
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
- Abstract:
-
β-Thalassemia is one of the most common inherited anemias, with no effective cure for most patients. The pathophysiology reflects an imbalance between α- and β-globin chains with an excess of free α-globin chains causing ineffective erythropoiesis and hemolysis. When α- thalassemia is co-inherited with β-thalassemia, excess free α-globin chains are reduced significantly ameliorating the clinical severity. Here we show the use of CRISPR/Cas9 genome editing of primary human hematopoietic stem/p...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
Bibliographic Details
- Publisher:
- Springer Nature Publisher's website
- Journal:
- Nature Communications Journal website
- Volume:
- 8
- Pages:
- 424
- Publication date:
- 2017-09-04
- Acceptance date:
- 2017-06-07
- DOI:
- EISSN:
-
2041-1723
- ISSN:
-
2041-1723
- Source identifiers:
-
698620
Item Description
- Keywords:
- Pubs id:
-
pubs:698620
- UUID:
-
uuid:894b01d4-5485-40bf-8d46-8748c110671c
- Local pid:
- pubs:698620
- Deposit date:
- 2017-06-07
Terms of use
- Copyright holder:
- Mettananda et al
- Copyright date:
- 2017
- Notes:
- Author(s) retain copyright; published by Nature Publishing Group under a Creative Commons Attribution 4.0 International License.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record